Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-19-001115
Filing Date
2019-09-27
Accepted
2019-09-27 16:10:15
Documents
1
Period of Report
2019-09-26

Document Format Files

Seq Description Document Type Size
1 form4-09272019_040902.html 4  
1 form4-09272019_040902.xml 4 7993
  Complete submission text file 0001415889-19-001115.txt   9595
Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address 950 WINTER STREET WALTHAM MA 02451 (858) 909-0749
Eloxx Pharmaceuticals, Inc. (Issuer) CIK: 0001035354 (see all company filings)

EIN.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O RADIUS HEALTH BOSTON MA 02139
Business Address
Ward Robert (Reporting) CIK: 0001595111 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31326 | Film No.: 191122221